Loading…
Orthopedic device firm Stryker has finalized its acquisition of surgical imaging technology developer Novadaq Technologies for approximately $710 million in cash.
The Ontario Superior Court of Justice has issued a final order approving Stryker Corporation's acquisition of all shares of NOVADAQ Technologies Inc. for US$11.75 per share in cash. The deal is expected to close in Q3 2017, pending regulatory approvals.
Stryker Corporation announced a definitive agreement to acquire NOVADAQ Technologies Inc. for US$11.75 per share, or US$701 million (net purchase price US$654 million). NOVADAQ is a developer of fluorescence imaging technology for surgical procedures.